Enliven Therapeutics, Inc. (ELVN) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$15,297
Total Return
52.97%
CAGR
8.87%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.10% |
| Median | -1.74% |
| Best | +116.09% |
| Worst | -44.81% |
| % of Windows Positive | 46.7% |
1-Year (252 Trading Days)
| Average | +51.08% |
| Median | +17.14% |
| Best | +438.55% |
| Worst | -87.79% |
| % of Windows Positive | 56.2% |
3-Year (756 Trading Days)
| Average | +124.15% |
| Median | +85.91% |
| Best | +407.01% |
| Worst | -45.45% |
| % of Windows Positive | 84.8% |
Risk Metrics
| Maximum Drawdown | -89.05% |
| Average Drawdown | -49.57% |
| Drawdown Duration | 1204 Trading Days |
| Sortino Ratio | 0.88 |
| Calmar Ratio | 0.10 |
| CVaR (5%) | -9.25% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +197.99% (+3533.82% ann.) | +$19798.65 | $0.00 | $0.00 | $0.00 |
| 2025 | -31.56% | $3155.55 | $0.00 | $0.00 | $0.00 |
| 2024 | +62.57% | +$6257.20 | $0.00 | $0.00 | $0.00 |
| 2023 | -15.40% | $1540.34 | $0.00 | $0.00 | $0.00 |
| 2022 | +81.78% | +$8177.80 | $0.00 | $0.00 | $0.00 |
| 2021 | -89.80% | $8979.59 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +47.00% (+61.39% ann.) | +$4700.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Pandemic shock / liquidity crash partial | March 12, 2020 – March 23, 2020 | +6.67% | +752.48% | +$666.67 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -0.19% | -0.30% | $18.61 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -83.27% | -81.66% | $8327.02 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +35.50% | +38.07% | +$3550.30 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +3.22% | +1.73% | +$322.10 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +110.89% | +59.98% | +$11089.13 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.